Br[C:2]1[S:3][CH:4]=[C:5]([Br:7])[N:6]=1.Cl.[CH:9]12[CH2:14][CH:13]1[CH2:12][NH:11][CH2:10]2.CCN(C(C)C)C(C)C>CN(C=O)C>[CH:9]12[CH2:14][CH:13]1[CH2:12][N:11]([C:2]1[S:3][CH:4]=[C:5]([Br:7])[N:6]=1)[CH2:10]2To a stirred solution of 2,4-dibromothiazole (0.5 g. 2.06 mmol) in DMF (15 ml) were added 3-azabicyclo[3.1.0]hexane hydrochloride (prepared according to the procedure given in Bioorganic and Medicinal Chemistry Letters, 2005, 15, 2093-2096, 0.27 g, 2.26 mmol) and DIPEA (0.80 g, 1.0 ml, 6.17 mmol) under a stream of nitrogen. The reaction was then stirred at 80° C. for 18 hrs; the progress of reaction was monitored by TLC. The reaction was quenched with cold water (20 ml) and extracted with ethyl acetate (3×30 ml). The combined organic layer was washed with water (2×10 ml), dried over sodium sulphate and concentrated to give crude compound; which was purified by flash column chromatography using 10% ethyl acetate in hexanes as an eluent to obtain the title compound (0.29 g, 58.5%). MS: m/z 246 (M+1).